Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.
Accelerating new rare disease therapies through collaboration agreement
Global award honors entrepreneurship, innovation, and personal commitment
Supporting rare disease diagnosis, education, and clinical research
Driving Accelerated Diagnosis and Treatment Development
Driving personalized, immune-based therapy to target patients’ own immune responses
CENTOGENE biomarker measures lyso-Gb1 levels in children
Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database
Artificial Intelligence verbessert die Diagnose seltener Erkrankungen, basierend auf der weltweit größten kuratierten...
Research findings may provide deeper understanding on the role of genes that can contribute to development of...
In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program.